CELLECTAR BIOSCIENCES INC's ticker is CLRB and the CUSIP is 15117F500. A total of 41 filers reported holding CELLECTAR BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 19 | -13.6% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 22 | -100.0% | 0.00% | – |
| Q4 2021 | $184,000 | -65.6% | 276,976 | -52.1% | 0.00% | – |
| Q3 2021 | $535,000 | +245.2% | 578,361 | +346.3% | 0.00% | – |
| Q2 2021 | $155,000 | +3775.0% | 129,603 | +5740.6% | 0.00% | – |
| Q1 2021 | $4,000 | -20.0% | 2,219 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | +66.7% | 2,219 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | 0.0% | 2,219 | -0.1% | 0.00% | – |
| Q2 2020 | $3,000 | -81.2% | 2,221 | -81.8% | 0.00% | – |
| Q1 2020 | $16,000 | -40.7% | 12,224 | -0.0% | 0.00% | – |
| Q4 2019 | $27,000 | -57.8% | 12,227 | -62.1% | 0.00% | – |
| Q3 2019 | $64,000 | -16.9% | 32,229 | -8.5% | 0.00% | – |
| Q2 2019 | $77,000 | -38.4% | 35,239 | -33.6% | 0.00% | – |
| Q1 2019 | $125,000 | +22.5% | 53,065 | -19.7% | 0.00% | – |
| Q4 2018 | $102,000 | +52.2% | 66,070 | +195.5% | 0.00% | – |
| Q3 2018 | $67,000 | – | 22,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,772,848 | $3,688,000 | 2.14% |
| Sio Capital Management, LLC | 2,331,123 | $4,849,000 | 0.99% |
| Consonance Capital Management LP | 4,074,074 | $8,474,000 | 0.79% |
| Altium Capital Management LP | 851,852 | $1,772,000 | 0.66% |
| Tri Locum Partners LP | 658,373 | $1,369,000 | 0.50% |
| Maven Securities LTD | 1,725,000 | $3,709,000 | 0.37% |
| SABBY MANAGEMENT, LLC | 499,030 | $1,038,000 | 0.20% |
| FNY Investment Advisers, LLC | 220,321 | $458,000 | 0.12% |
| 683 Capital Management, LLC | 925,925 | $1,926,000 | 0.09% |
| Boxer Capital, LLC | 920,000 | $1,914,000 | 0.06% |